Deep Track Capital Fund I

Deep Track Capital

cb Email

Status

ACTIVE

Global HQ

Greenwich, United States

Countries of investment

United States
Denmark
United Kingdom
Germany
Switzerland
Canada

Investment stages

Series B
Series C
Growth

Industries

Biotechnology
Life Sciences
Healthcare
Therapeutics

About
Deep Track Capital is a Greenwich, Connecticut-based investment firm founded in 2020 by David Kroin, former co-founder of Great Point Partners. The firm employs a fundamentally driven, research-intensive strategy focused on biotechnology and healthcare. Deep Track manages over $5.6 billion across public and pre-IPO biotech holdings, with a team of 19 healthcare finance professionals.

Min check size: $5M
Max check size: $50M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Deep Track Capital focuses exclusively on the life sciences industry, developing long-term partnerships with management teams of leading innovative public and pre-IPO biotechnology companies. The firm aims to lead transactions while building large syndicates.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Deep Track Capital is led by Founder and Chief Investment Officer David Kroin, who brings decades of biotech and life sciences investing experience. David was previously co-founder of Great Point Partners and started his career at J.H. Whitney & Co and Merrill Lynch, holding a degree from the University of Michigan. He is joined by Managing Director Rael Mazansky and a team of 19 healthcare finance professionals who employ a fundamentally driven, research-intensive strategy focused on public and pre-IPO biotechnology.